Genome Sequencing Reveals Loci under Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat by Atanur, Santosh et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genome Sequencing Reveals Loci under Artificial Selection that
Underlie Disease Phenotypes in the Laboratory Rat
Citation for published version:
Atanur, S, Diaz, AG, Maratou, K, Sarkis, A, Rotival, M, Game, L, Tschannen, M, Kaisaki, P, Otto, G, Ma,
MCJ, Keane, T, Hummel, O, Saar, K, Chen, W, Guryev, V, Gopalakrishnan, K, Garrett, M, Joe, B, Citterio,
L, Bianchi, G, Mcbride, M, Dominiczak, A, Adams, D, Serikawa, T, Flicek, P, Cuppen, E, Hubner, N,
Petretto, E, Gauguier, D, Kwitek, A, Jacob, H & Aitman, T 2013, 'Genome Sequencing Reveals Loci under
Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat' Cell, vol. 154, no. 3, pp. 691-
703. DOI: 10.1016/j.cell.2013.06.040
Digital Object Identifier (DOI):
10.1016/j.cell.2013.06.040
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Cell
Publisher Rights Statement:
Under a Creative Commons license
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Resource
Genome Sequencing Reveals Loci
under Artificial Selection that Underlie
Disease Phenotypes in the Laboratory Rat
Santosh S. Atanur,1,2 Ana Garcia Diaz,1 Klio Maratou,1 Allison Sarkis,5 Maxime Rotival,3 Laurence Game,4
Michael R. Tschannen,5 Pamela J. Kaisaki,6 Georg W. Otto,6 Man Chun John Ma,7 Thomas M. Keane,8 Oliver Hummel,9
Kathrin Saar,9 Wei Chen,9 Victor Guryev,10,11 Kathirvel Gopalakrishnan,12 Michael R. Garrett,13 Bina Joe,12
Lorena Citterio,14 Giuseppe Bianchi,14 Martin McBride,15 Anna Dominiczak,15 David J. Adams,8 Tadao Serikawa,16
Paul Flicek,17 Edwin Cuppen,10 Norbert Hubner,9,18 Enrico Petretto,3 Dominique Gauguier,6,19 Anne Kwitek,7
Howard Jacob,5 and Timothy J. Aitman1,*
1Physiological Genomic and Medicine Group, MRC Clinical Sciences Centre
2National Heart and Lung Institute
3Integrative Genomics and Medicine Group, MRC Clinical Sciences Centre
4Genomics Core Laboratory, MRC Clinical Sciences Centre
Imperial College London, London W12 0NN, UK
5Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
6The Welcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
7Department of Pharmacology, University of Iowa, Iowa City, IA 52242, USA
8The Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK
9Max Delbruck Center for Molecular Medicine, Berlin 13092, Germany
10Hubrecht Institute KNAW and University Medical Center Utrecht, Uppsalalaan 8, 3584 Utrecht, the Netherlands
11European Research Institute for the Biology of Ageing, University Medical Center, 9700 AD Groningen, the Netherlands
12Center for Hypertension and Personalized Medicine, Department of Physiology and Pharmacology, University of Toledo College
of Medicine, Toledo, OH 43606-3390, USA
13Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA
14San Raffaele Scientific Institute, OU Nephrology, University Vita Salute San Raffaele, Chair of Nephrology, 58, 20132 Milan, Italy
15Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK
16Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
17European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton,
Cambridge CB10 1SD, UK
18DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin 13092, Germany
19INSERM UMR-S872, Cordeliers Research Centre, 75006 Paris, France
*Correspondence: t.aitman@csc.mrc.ac.uk
http://dx.doi.org/10.1016/j.cell.2013.06.040
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARY
Large numbers of inbred laboratory rat strains have
been developed for a range of complex disease
phenotypes. To gain insights into the evolutionary
pressures underlying selection for these pheno-
types, we sequenced the genomes of 27 rat strains,
including 11 models of hypertension, diabetes, and
insulin resistance, along with their respective control
strains. Altogether, we identifiedmore than 13million
single-nucleotide variants, indels, and structural var-
iants across these rat strains. Analysis of strain-spe-
cific selective sweeps and gene clusters implicated
genes and pathways involved in cation transport,
angiotensin production, and regulators of oxidative
stress in the development of cardiovascular disease
phenotypes in rats. Many of the rat loci that we iden-tified overlap with previously mapped loci for related
traits in humans, indicating the presence of shared
pathways underlying these phenotypes in rats and
humans. These data represent a step change in
resources available for evolutionary analysis of com-
plex traits in disease models.INTRODUCTION
In the past 100 years, more than 500 inbred rat strains have been
derived for a range of physiological and pathophysiological
phenotypes (Aitman et al., 2008; Lindsey, 1979) but have been
predominantly used to study cardiovascular and metabolic phe-
notypes, which are complex traits governed by the interaction
between multiple genetic factors and the environment. Inbred
rat models of cardiovascular and metabolic phenotypes have
been derived from various founder colonies or stocks atCell 154, 691–703, August 1, 2013 ª2013 The Authors 691
various geographic locations by crossing relatively small
numbers of rats within the colony and selecting for the desired
disease phenotypes over several generations, with simultaneous
or subsequent brother-sister mating to develop genetically
homogeneous inbred strains (Jong, 1984; Rapp, 2000).
Although themajority of inbred rat models of hypertension and
diabetes were generated from outbred Wistar colonies, efforts
have been made to derive disease models on various other
genetic backgrounds (Jong, 1984). Each strain so derived is
therefore expected to show major founder effects and should
be genetically and phenotypically distinct from its founder colony
as well as from other strains derived from different founder col-
onies (Doggrell and Brown, 1998). Significant genotypic and
phenotypic heterogeneity in the genetic models of hypertension
and diabetes therefore provides a unique resource to study
molecular mechanisms behind different etiological forms of
hypertension. In addition, metabolic phenotypes such as insulin
resistance and dyslipidaemia, which were frequently co-in-
herited with hypertension and may form part of the hypertension
phenotype, may have inadvertently been coselected with hyper-
tension, as well as compensatory alleles that protect against
target organ damage mediated by phenotypes such as hyper-
tension (St Lezin et al., 1999).
We hypothesize that, in these rat strains, phenotype-driven
selection may have resulted in ‘‘artificial selective sweeps’’
with fixation of sequence variants that underlie disease pheno-
types, as has been observed in the artificial selection of a number
of other disparate but benign traits in different species (Rubin
et al., 2010;Wright et al., 2005; Xia et al., 2009). Artificial selective
sweeps in inbred rat strains may be unique to a particular strain
and disease phenotype in comparison with other strains and
may contribute to the molecular basis of hypertension and other
related phenotypes in that strain.
Genes in a genome evolve at different evolutionary rates due
to varying evolutionary constraints on each gene, and interac-
tions between genes underlying complex phenotypic traits are
maintained by coevolution (Pagliarini et al., 2008; Tillier and
Charlebois, 2009). Because of the polygenic nature of hyperten-
sion and other complex phenotypes, genes containing disease-
inducing variants might have evolved together at an evolutionary
rate that will be different from the rest of the genome. The
identification of genes that have coevolved and of artificial
selective sweeps in rat disease models may therefore be infor-
mative for identifying loci underlying disease phenotypes and
for understanding the polygenic architecture of complex disease
phenotypes.
Present sequencing technology now permits rapid and accu-
rate sequencing of whole genomes through which near-com-
plete catalogs of genomic variants can be obtained. It is therefore
possible to perform, in model organisms, genomic screening for
identification of coevolved gene clusters and artificial selective
sweeps that harbor potentially pathogenic genes andmutations.
In this study, we sequenced the genomes of 25 new rat strains
on high-throughput sequencing platforms, with a major focus on
strains with well-characterized cardiovascular and metabolic
phenotypes. These included 11 widely used rat models of hyper-
tension, diabetes, and insulin resistance, along with their respec-
tive control strains. We identified a comprehensive catalog of692 Cell 154, 691–703, August 1, 2013 ª2013 The Authorsgenomic variants in 27 rat strains (25 strains sequenced for
this study and two strains sequenced previously; Atanur et al.,
2010; Simonis et al., 2012). We also identified clusters of genes
and genomic loci that coevolved during selective breeding of
these laboratory rat strains and established their relationship to
genes and loci known to underlie disease phenotypes in these
strains. The study therefore provides insights into the genetics
and biology of cardiovascular and metabolic phenotypes shown
by the sequenced rat strains.
RESULTS
Sequencing and Variant Calling
We sequenced the genomes of 25 rat strains and analyzed them
together with the genomes of two rat strains that we sequenced
previously (Atanur et al., 2010; Simonis et al., 2012). We also re-
sequenced the genome of BN/Mcwi to correct for errors in the
reference genome, using DNA from the same animal that was
used for the reference BN genome sequence (Gibbs et al.,
2004). Quality filtered sequence reads were mapped to the
reference BN/Mcwi genome assembly (referred to hereafter as
the BN reference), version RGSC3.4. After removing clonal
reads, we achieved at least or close to 203 coverage for all
strains except for strains BBDP/Wor and WKY/NHsd, for which
we achieved 103 coverage (Table 1).
After applying rigorous filtering criteria (see Extended Experi-
mental Procedures available online) and excluding genomic
variants that arose due to potential errors in the reference
genome (in which the reference allele was different from the
BN/Mcwi allele detected by resequencing), 9,665,340 single-
nucleotide variants (SNVs) and 3,502,117 short indels were iden-
tified across the 27 rat strains (Table 1). This includes 839,691
SNVs and 479,974 indels, in which we could not determine the
BN/Mcwi allele by resequencing because of either low coverage
or poor read mapping and/or base quality. The variant set there-
fore may still contain a small proportion (0.001%) of false posi-
tives due to base call errors in the reference BN genome. We
found that 98.3% of SNV calls were homozygous and 1.7%
were heterozygous, the latter most likely arising from a combina-
tion of true heterozygote loci due to incomplete fixation of the
inbred strain and false-positive calls due to regions of copy num-
ber variation, sequencing errors, and mapping errors in highly
repetitive genomic regions, as previously described (Atanur
et al., 2010; Keane et al., 2011). Along with SNVs and indels,
we also identified a total of 719,929 structural variants in the
26 rat strains sequenced on the Illumina platform.
To assess the sensitivity and specificity of the variant calls, we
compared the LE/Stm Illumina sequence with the publicly avail-
able sequence of 13 bacterial artificial chromosomes (BACs)
derived from the LE/Stm genome generated by conventional
capillary sequencing, which provided a control sequence region
of 2 Mb for LE/Stm. There were 3,382 SNVs and 1,211 indels
identified in the LE/Stm BAC sequences compared to the BN
reference genome. We estimated 0.38% false-positive and
8.1% false-negative SNV calls in the Illumina LE/Stm sequence,
with an estimated false positive and false negative rate for indels
of 3.75% and 10.98%, respectively. Thus the overall accuracy
of genotype calls, including variant and reference calls, was
Table 1. Sequencing Details and Variant Calls in 27 Inbred Rat Strains
Rat Strain
Gb of Bases
Mappeda Average Coveragea Number of SNVsb Number of Indelsb
Number of Structural
Variantsb
ACI/EurMcwi 86.64 33.69 3,607,275 1,168,780 17,859
BBDP/Wor 25.68 9.99 3,322,410 1,131,697 35,387
BN.Lx 58.40 22.71 51,938 45,404 NA
F344/NCrl 65.13 25.33 3,433,241 1,132,993 42,138
FHH/EurMcwi 57.98 22.55 3,471,696 1,170,337 22,628
FHL/EurMcwi 53.25 20.71 3,422,550 1,117,039 14,217
GK/Ox 75.25 29.26 3,584,504 1,147,996 58,877
LE/Stm 56.11 21.82 3,485,480 1,152,163 19,285
LEW/NCrlBR 51.06 19.86 2,966,945 1,014,796 39,031
LEW/Crl 66.30 25.78 2,941,368 1,002,364 39,146
LH/MavRrrc 55.84 21.71 3,459,239 1,189,791 21,901
LL/MavRrrc 58.04 22.57 3,419,697 1,177,989 20,623
LN/MavRrrc 56.54 21.99 3,406,103 1,171,795 20,561
MHS/Gib 64.68 25.15 3,270,047 1,112,526 23,551
MNS/Gib 57.26 22.27 3,278,667 1,123,980 22,769
SBH/Ygl 65.76 25.57 3,461,088 1,134,320 13,789
SBN/Ygl 47.17 18.34 3,334,857 1,078,851 9,586
SHR/NHsd 61.25 23.82 3,795,348 1,222,619 45,284
SHR/OlaIpcv 52.72 20.5 3,832,318 1,276,189 11,781
SHRSP/Gla 70.03 27.23 3,735,521 1,174,933 14,665
SR/Jr 50.28 19.55 3,421,364 1,140,725 36,798
SS/JrHsdMcwi 55.82 21.71 3,383,380 1,136,032 11,124
SS/Jr 51.42 19.99 3,377,708 1,110,653 38,535
WAG/Rij 53.58 20.84 3,167,781 1,084,318 51,423
WKY/Gla 68.17 26.51 3,819,860 1,234,622 11,310
WKY/NHsd 30.02 11.67 3,877,157 1,313,104 31,875
WKY/NCrl 63.77 24.8 3,718,449 1,250,041 45,788
See also Figure S1 and Tables S1 and S2.
aGb of bases mapped and average coverage were calculated after removing clonal reads.
bNumbers of sequence variants relative to the BN reference genome.99.99% for the LE/Stm genome, which can be scaled to the re-
maining 25 rat strains sequenced on the Illumina platform, as the
variants were called in these strains simultaneously with the
same methods.
Within the total set of 9,665,340 identified SNVs, 67,616 were
in protein-coding sequence, among which 29,131 were nonsy-
nonymous coding (NSC) variants and 38,485 were synonymous
coding (SC) variants. Of the 29,131 NSC variants, 409 predicted
premature truncation of the protein due to gain of stop codons,
whereas 27 predicted the loss of stop codons (Table S1 and Fig-
ures S1A and S1B). We also identified 2,366 short indels in pro-
tein-coding sequence, which predicted disruption of the open
reading frame of the encoded protein (Table S2 and Figures
S1C and S1D). Of the observed 37,510 large deletions, 1,497
overlapped with the predicted protein-coding sequence.
Phylogenetic History of Laboratory Rat Strains
The evolutionary history of laboratory rat strains is complex, as
they were derived by multiple rounds of interbreeding and
inbreeding in different locations at different points in time(Jong, 1984; Saar et al., 2008). To inform understanding of the
evolutionary history of laboratory rat strains, we constructed a
phylogenetic tree of strains, including the BN reference strain,
using our catalog of 9.6 million high-quality SNVs. Laboratory
rat strains clustered essentially according to founder stocks
and colonies from which they were derived (Figure 1). Moreover,
Wistar-derived strains showed two prominent subclusters,
consistent with the known breeding history of Wistar-derived
strains in Japan (SHR, SHRSP, GK, and WKY) or elsewhere in
Europe and the USA (MHS, MNS, LEW, WAG, and BBDP).
Sprague-Dawley-derived (SD) strains (SS, SR, LH, LL, and LN)
also clustered together, whereas other strains formed more iso-
lated clusters, including BN strains from which the reference
genome strain (BN/Mcwi) was selected. The WKY/Gla strain
was closer to SHR substrains than other WKY substrains,
possibly reflecting the known diversity of WKY strains arising
from their distribution to different geographical locations before
complete inbreeding (Kurtz et al., 1989) or from the close rela-
tionship of SHR and WKY sublines during their establishment
and maintenance.Cell 154, 691–703, August 1, 2013 ª2013 The Authors 693
Figure 1. Phylogenetic Tree of 28 Rat
Strains
The phylogenetic tree was constructed using 9.6
million SNVs across 28 laboratory rat strains,
including the Brown Norway reference strain (BN/
Mcwi). The scale represents genetic distance; the
distance matrix was calculated by dividing the
number of SNVs between a given pair of strains
by the length of the BN reference genome. The
phylogenetic tree was constructed using the Fitch-
Margoliash method with 1,000 bootstraps.Coevolutionary Gene Clusters
Because rat models of hypertension, insulin resistance, and
diabetes were selectively bred for these genetically complex dis-
ease phenotypes, the genes underlying these phenotypes may
have been coselected and coevolved because of the selective
pressure exerted on them during the derivation of these strains.
Functionally related genes with a similar evolutionary rate tend to
have a similar phylogenetic history (Pagliarini et al., 2008). To
identify clusters of genes that coevolved during selection for
complex traits, we used a mirror tree approach (Pazos and Va-
lencia, 2001), as illustrated in Figure 2, to test the hypothesis
that genetic effects on disease phenotypes may be detectable
as coevolved variation in protein-coding sequence between rat
strains. Coevolutionary gene clusters were identified using tran-
scripts that show NSC variants, including SNVs causing a stop
gain or stop loss in at least one strain compared to the reference
BN genome. We calculated evolutionary rate by dividing the
number of NSC variants in a transcript by the number of SC var-
iants in the same transcript, both normalized by the length of the
transcript. This defined a phylogenetic vector for each transcript.
Similarly phylogenetic vectors were calculated for each tran-
script showing frameshift due to indels.
To take into account the effect of population structure on
evolutionary rate, we used SNV data across the strains to esti-
mate principal components contributing to variability in the
strains (Sato et al., 2005). The first two principal components
were found to explain 70% of the sequence variability across
strains (Figure S2A) and clearly separate Japanese Wistar-
derived strains, SD-derived strains, and the remaining rat
strains (Figure S2B). We adjusted the evolutionary rate for the694 Cell 154, 691–703, August 1, 2013 ª2013 The Authorsfirst two principal components and
then calculated correlation coefficients
between the residuals for all possible
pairwise combinations (89,024,496) of
transcripts containing NSCSNVs. Coevo-
lutionary clusters were then identified
using 310,690 pairs of transcripts with
significant correlation (j r j > 0.96;
p value < 9.33 3 1015; FDR < 0.1%). A
total of 1,955 clusters were identified
(Table S3A), the majority of them contain-
ing two (n = 1063) or three (n = 383) tran-
scripts, whereas 109 clusters contain 10
or more transcripts (Table S3A). Confirm-
ing the cluster analysis, for 1,133 clusters,more than 40% of the NSC mutations represented within the
cluster showed linkage disequilibrium (LD; r2 > 0.8) with each
other, and the majority of them showed perfect LD (r2 = 1) even
though SNVs were located on different chromosomes. After
random shuffling of the SNVs, this LD structure was completely
lost (Figure S3), suggesting that mutations in these genes may
have coevolved under the same selection pressures. Relatively
smaller numbers (n = 145) of clusterswere identified using frame-
shift coding mutations (Table S3B) because only 1,634 of the
transcripts show frameshift coding mutations in at least one
strain compared to the BN reference genome.
To corroborate the data generated from principal component
analysis (PCA), we also used the R package EMMA (Kang et al.,
2008), which is based on a linear mixed model to correct for
population structure and genetic relatedness in model organism
association mapping, to identify coevolutionary gene clusters.
The networks obtained from EMMA showed high concordance
with the networks obtained from PCA-based population struc-
ture correction, with 75% of edges shared between the two
networks (p value for significant overlap < 1016). The number
of shared edges was raised to an average of 94% (min 72%,
max 100%) when considering edges in clusters identified from
PCA-derived networks that were unique to a single strain
(Table S4).
The majority of the large clusters contain transcripts mutated
either uniquely in a single strain or in strains that were derived
from the same founder colony and show close genetic proximity
in the phylogenetic tree. For example, the two fawn-hooded rat
strains FHH and FHL shared NSC variants in 311 transcripts
that were unique just to these strains, and the Wistar-derived
Figure 2. Illustration of the Mirror Tree Approach
In this illustration, hypothetical genes 1, 4, and 6 evolved together, as they show identical phylogenetic history, whereas genes 2 and 5 also show an identical
evolutionary history, though these two groups of genes evolved at a different evolutionary rate. These evolutionary patterns of individual genes were converted
into phylogenetic vectors. Phylogenetic vectors of coevolving genes such as genes 1, 4, and 6 aremore highly correlated than those that evolved at different rates
such as genes 2 and 6. Networks of genes that coevolved were generated from significantly correlated genes. Phylogenetic vectors were derived by taking into
account population structure.
See also Figure S2 and Tables S3, S4, and S8.SHR, SHRSP, and WKY strains uniquely shared NSCs in 140
transcripts (Table S3A). However, the finding of NSC or frame-
shift variants shared between strains that originated from the
same founder population irrespective of their disease status,
for example, between a hypertensive strain and its respective
normotensive control, indicates that they are unlikely to be
responsible for disease phenotypes and are more likely a reflec-
tion of shared ancestry. We therefore sought clusters of
coevolved transcripts that were unique to strains selected for
disease phenotypes. Such clusters would be unique to an
individual disease strain and would not be found even in the
respective control strains with which they share immediate com-
mon ancestors, minimizing the likelihood that the clusters have
arisen because of shared ancestry.
A unique coevolutionary cluster was identified in each disease
model, the largest of which was found in the GK strain (Tables 2
and S5A). We also identified clusters of transcripts that were
uniquely mutated in all disease models derived from the same
founder, but not in the respective control strains. For example,
clusters of transcripts that were mutated were identified inWistar-derived strains SHR, SHRSP, and GK, but not in control
strain WKY (Table S5B), and in the SD-derived disease models
SS and LH, but not in control strain SR, LL, and LN (Table
S5C). Because these NSC variants were unique to or were
shared between these disease models and are not present in
the respective control strains, it is plausible that a proportion of
these were coselected and coevolved throughout the selective
inbreeding process and contribute causally to the disease
phenotype.
The Milan hypertensive rat strain (MHS) was derived from an
outbred Wistar colony along with the normotensive MNS control
strain. Hypertension in MHS rats has been shown to be due
to excess renal sodium reabsorption (Bianchi et al., 1986). We
identified a cluster of 65 transcripts (47 genes) showing NSC
sequence variants and a cluster of 5 transcripts (4 genes)
showing frameshift coding variants in MHS (Tables S5D and
S5E). Importantly, the NSC cluster contains the Add1 gene
encoding Alpha-adducin, in which the amino acid substitution
F316Y has been identified as a cause of hypertension in MHS
(Bianchi et al., 2005; Ferrandi et al., 2010). Polymorphisms inCell 154, 691–703, August 1, 2013 ª2013 The Authors 695
Table 2. Coevolutionary Gene Clusters Derived from
Nonsynonymous and Frameshift Variants in Disease Models
Strain
Number of Transcripts
in NSC Variant Clustera
Number of Transcripts
in Frameshift Variant Clustera
BBDP 63 (47) 16 (12)
FHH 59 (46) 4 (4)
GK 230 (164) 22 (22)
LH 16 (15) 3 (2)
MHS 65 (47) 5 (4)
SBH 129 (103) 12 (12)
SHR 12 (12) 2 (2)
SHRSP 51 (39) 3 (2)
SS 35 (17) 4 (2)
NSC variants, nonsynonymous coding variants. See also Figure S3 and
Table S5.
aGenes shown in parentheses.the human ADD1 gene have also been associated with
hypertension and responsiveness to antihypertensive medica-
tions in several populations (Cusi et al., 1997; Li, 2012). We
also identified, along with Add1, genes Slc4a2, Slc12a8, and
Atp13a4, which show NSC mutations in MHS. Slc4a2 encodes
the anion exchange protein 2, which has shown evidence for
association with human hypertension (So˜ber et al., 2009).
Slc12a8 belongs to the cation chloride cotransporter family
(Hebert et al., 2004), and Atp13a4 encodes a cation-transporting
P-type ATPase (Kwasnicka-Crawford et al., 2005). In light of
longstanding observations on the relationship between ion
transport and hypertension in rats and humans (Bianchi et al.,
1990; Lifton et al., 2001), the physiological consequences of
mutations in these ion transporters merit further investigation.
The BBDP rat strain is an extensively studied model of
type 1 diabetes, occurring in association with profound T cell
lymphopenia with severe reduction or absence of CD4 and
CD8 T cells (Jackson et al., 1983). We identified a cluster of
63 transcripts (47 genes) showing NSC variants and also 16
transcripts (12 genes) showing frameshift variants that are
unique to BBDP (Tables S5F and S5G). The frameshifts include
a 1 base pair (bp) deletion in Gimap5, a member of the GTPase
of the immunity-associated protein family. This frameshift
mutation was previously identified as the cause of T cell lym-
phopenia in BBDP (Dalberg et al., 2007; Hornum et al., 2002;
MacMurray et al., 2002). The finding that two genes identi-
fied previously as disease susceptibility genes in MHS and
BBDP were among the small gene sets that we defined as
uniquely variant in these strains using coevolutionary cluster
analysis suggests that genes underlying other QTLs are
likely to be found within the coevolved gene sets of these
and other disease strains and that these gene sets should be
prioritized in future investigations of disease phenotypes in
these strains.
Although we identified clusters that were shared between dis-
ease models derived from different founder colonies such as
BBDP and MHS (n = 17 transcripts) or GK and SBH (n = 17 tran-
scripts), no clusters were found that revealed potentially func-
tional mutations across all models of hypertension, diabetes,696 Cell 154, 691–703, August 1, 2013 ª2013 The Authorsor insulin resistance. Surprisingly, clusters were not found even
in rat strains showing spontaneous hypertension (FHH, MHS,
SHR, SHRSP, and LH) or salt-induced hypertension (SS and
SBH), most likely reflecting heterogeneity in hypertension and
related phenotypes among these rat strains.
Next, we investigated whether the human orthologs of rat
genes either shared between or uniquely mutated in rat disease
models had been associated in human genome-wide associa-
tion studies (GWAS) for hypertension, metabolic phenotypes,
or their complications. We found that such genes were signifi-
cantly overrepresented in GWAS hits for hypertension or meta-
bolism-related phenotypes (Fisher’s exact test p value = 104),
suggesting that genes represented in clusters containing unique
NSC mutations in disease models had not only coevolved, but
were also functionally related and may also contribute to these
or related disease phenotypes in humans.
Identification of Artificial Selective Sweeps
To identify selective sweeps that may have arisen during pheno-
type-driven selective breeding, we identified genomic regions
that were either unique to or shared between multiple strains.
At a p value of less than 105 (corresponding to FDR < 0.1%),
15,859 separate genomic segments were significantly shared
between two ormore strains or were unique to a particular strain,
with segment sizes ranging from 20 kb to 2.9 Mb (Table S6).
Moreover, of these 15,859 regions, 189 were unique to a single
rat strain, of which 96were unique to one of the 11models of car-
diovascular or metabolic disease. Examples of genomic seg-
ments that were present uniquely in FHH and SS, but not in
any other strains, including their respective control strains, are
shown in Figure 3A. Of all SNVs that were unique to a single
strain, 50% reside within the 189 segments that were unique
to a single strain. Because these 189 segments occupy only
0.8% of the genome, these data indicate that private SNVs are
not randomly distributed throughout the genome but instead
are highly concentrated in a small number of discrete regions
of the genome.We hypothesize that private SNVs that are unique
to a single strain reside within these regions because many of
these regions were positively selected in the initial phenotype-
driven derivation of these strains. These regions may therefore
be enriched for selective sweeps. We term these regions puta-
tive artificial selective sweep (PASS) regions.
Because regions under selection pressure tend to have
elevated linkage disequilibrium (LD) (Xia et al., 2009), we esti-
mated the pairwise LD between all of the SNVs within the
detected PASS regions. Across the whole genome, strong LD
was observed between adjacent pairs of SNVs. LD decay was
slow and r2 reduced to 50% of maximum at a mean distance
of 11 kb, although average r2 was greater than 0.2 even at a
distance of 0.5 Mb (Figure 3B). Within PASS regions, however,
there was almost no decay of LD, and at a distance of 0.5 Mb,
r2 was 4-fold higher in PASS regions than the genome-wide
average (Figure 3B). This strong LD completely disappeared
after permutation of the SNVs (Figure S4). The increased LD in
these regions validates the method used to detect PASS regions
and is consistent with the hypothesis that these regions were
under positive selection pressure during the original derivation
of these strains.
Figure 3. Examples of Putative Artificial
Selective Sweep Regions Identified in Labo-
ratory Rat Strains
(A) Relative SNV density (RSD) in 10 kb windows
for four rat strains plotted along rat chromosomes
separated by colors. Black arrows indicate puta-
tive artificial selective sweep (PASS) regions
identified in respective rat strains. Closely adjacent
but distinct PASS regions on the same chromo-
some are represented by a single arrow. The PASS
region on chromosome 7 in SS is adjacent to but
not overlapping with the chromosome 7 PASS
region in SR. (For detail, see Table S6).
(B) Average linkage disequilibrium (LD) between
pairs of SNVs within a distance ranging from 1 bp
to 0.5 Mb. The blue line represents average LD at
whole-genome level; the red line represents LD in
PASS regions.
(C) Distribution of Tajima’s D in 10 kb windows in
the entire genome (blue line) and in PASS regions
(red line).
(D) Ratio of nonsynonymous coding (NSC) variants
to synonymous coding (SC) variants at genome
level (blue bar) and in PASS regions (red bar).
See also Figure S4 and Tables S6 and S7.To assess whether the PASS regions identified by the RSD
analysis were due to the varying demographic history of the rat
strains or, alternatively, were due to the effects of selection pres-
sures exerted during derivation of the strains, we performed coa-
lescent simulations that accounted for the known demographic
history of the 22 laboratory rat strains, but not for the selection
pressure exerted on them. In our null model, obtained by simula-
tion on demographic history without phenotypic selection, no
genomic region unique to a strain with length greater than
40 kb was observed, with a statistically unlikely probability of
observing unique haplotype blocks of length 40 kb (p = 0.0003)
or 30 kb (p = 0.002). All of the PASS regions that we identified
were longer than or equal to 30 kb, and some were more than
1 Mb (Table S6). The identification of PASS regions that were
considerably longer than those observed under the null model
without selection provides evidence that PASS regions are
enriched for positively selected haplotype blocks.
As further evidence that the identified PASS regions were
positively selected during the phenotype-driven derivation of
these strains, we estimated the population genetics parameter
Tajima’s D in each 10 kb window used for identification of
PASS regions. FDR was calculated using the null distribu-
tion of Tajima’s D derived from the coalescent simulation
data. PASS regions showed highly negative Tajima’s D values
(Figure 3C), with more than 70% of the 10 kb windows
within the PASS regions showing Tajima’s D less than 2.08
(FDR% 0.05).Cell 154, 691–70Functional Significance of
Selective Sweeps
As an initial test of whether the identified
PASS regions are of functional signifi-
cance, we estimated the ratio of NSC var-
iants to SC variants in PASS regions.PASS regions were highly enriched for NSC mutations as
compared to the rest of the genome, with an NSC to SC ratio
of 1.65 and 0.76, respectively, in PASS regions and across the
whole genome (Fisher’s exact test p value = 2.19 3 105;
Figure 3D).
We next assessed what proportion of PASS regions colocal-
ized with known physiological quantitative trait loci (pQTLs) for
the metabolic and cardiovascular phenotypes manifested in
these strains. Of the 96 PASS regions that were unique to 1 of
the 11 cardio-metabolic disease strains, 25 were colocalized
with pQTLs reported in RGD (http://rgd.mcw.edu/) in the same
strain in which each PASS region was identified. This overlap
was marginally significant compared to the overlap expected
by chance (permutation test p value = 0.04). Interestingly, the
majority (78%) of the PASS regions were localized either directly
under or in close proximity (10Mb) to a peak of at least oneQTL
linkage (Table S7).
To identify genes and pathways that may have contributed to
phenotype-driven selection during generation of disease strains,
we carried out gene ontology (GO) and KEGG pathway analyses
of genes in the PASS regions in these strains. Only two strains,
SS and FHH, showed significant enrichment (p < 0.05) for spe-
cific biological processes or pathways. In FHH, 44 genes reside
within 14 FHH-specific PASS regions (Figure 3A), and thesewere
enriched for genes involved in the renin-angiotensin system
(RAS) and in proteolysis (p = 3.4 3 104 and 1.6 3 108,
respectively).3, August 1, 2013 ª2013 The Authors 697
Figure 4. FHH PASS Regions on Chromo-
some 15
(A) Blue dots represent relative SNV density (RSD)
in 10 kb windows for the FHH rat strain on chro-
mosome 15. The genomic region unique to the
FHH strain is highlighted by the gray dotted lines.
Heatmap (bottom) showing RSD in the genomic
region unique to FHH and flanking regions across
all laboratory rat strains sequenced. Only the FHH
rat strain showed an RSD value equal to 100.
Remaining strains showed an RSD value of zero
across almost all of the PASS regions, indicating
that only the FHH strain shows SNVs against
the BN reference genome in this region. Linkage
disequilibrium (LD) structure of SNVs in the
genomic region unique to FHH show that98% of
the SNVs in this region were in significant LD.
(B)Tajima’s D in genomic region unique to FHH rat
strain. The PASS region unique to FHH is high-
lighted, showing highly negative Tajima’s D value.
(C) The genomic region unique to FHH shows a
markedly increased ratio of NSC to SC variants.Three genes within FHH PASS regions were components of
RAS, including Cma1 and CtsG, both of which are reported to
mediate non-angiotensin conversion enzyme (ACE)-dependent
conversion of angiotensin I to angiotensin II (Uehara et al.,
2013). The RAS system is central to the regulation of blood pres-
sure in all mammals, and FHH rats show reduced sensitivity to
angiotensin II, which has been proposed as a cause of FHH sus-
ceptibility to renal disease (van Rodijnen et al., 2002). In humans,
a haplotype at CMA1 has been weakly associated (p = 23 104)
with hypertension in Han Chinese (Wu et al., 2012), and in mice,
chymase 1 has been proposed to modulate regulation of blood
pressure by angiotensin II (Li et al., 2004). In addition, ACE inhib-
itors and angiotensin receptor blockers are among the most
widely used antihypertensive agents (Kobori et al., 2007). Cma1
and Ctsg have NSC sequence variants that are unique to FHH
among rat strains (His/Arg inCma1; Ala/Thr inCtsg). The his-
tidine at codon 94 in Cma1 is conserved in all mammals. Cma1
and Ctsg are therefore compelling candidates as regulators of
blood pressure in FHH and, because of their enzymatic function
in non-ACE-dependent conversion of angiotensin I to angio-
tensin II, are potential novel antihypertensive drug targets.
The 44 genes in FHH-specific PASS regions have a markedly
increased NSC-to-SC ratio (Figure 4C) and are highly enriched
for GO biological processes related to proteolysis. The 12
genes in this GO category are all mast cell proteases or belong
to the family of granzymes, which are also expressed in mast
cells and reside within five FHH PASS regions on a 2.13 Mb
segment of chromosome (Chr) 15 that shows highly negative
Tajima’s D (Figures 4A and 4B). Ten of these genes have698 Cell 154, 691–703, August 1, 2013 ª2013 The AuthorsNSC variants that are unique to FHH.
FHH rats develop glomerulosclerosis
and interstitial fibrosis with glomerular
hyperfiltration, albuminuria, and end-
stage renal failure (de Keijzer et al.,
1988; Kreisberg and Karnovsky, 1978;
Kriz et al., 1998). A consomic study inwhich FHH chromosomes were substituted with BN chromo-
somes showed that substitution of Chr 15 resulted in reduced
blood pressure, albuminuria, and glomerular damage, indi-
cating that genetic determinants of these phenotypes reside
on FHH Chr 15 (Mattson et al., 2007). Mast cell numbers are
increased in human hypertensive nephropathy and are associ-
ated with renal disease in the context of nephrectomy-induced
hyperfiltration (Welker et al., 2008). Among the granzymes and
mast cell proteases within the Chr 15 PASS regions, GzmF and
Mcpt10 contain nonconservative amino acid substitutions
(Lys/Gln and Gly/Cys, respectively). Taken together, these
data implicate this segment of Chr 15 and specifically the
unique FHH variation in granzymes and mast cell proteases in
the development of hypertension-induced renal damage in
this rat strain.
In SS, 16 protein-coding genes reside within 4 SS-specific
PASS regions (Figure 3A and Table S6), and these were enriched
for aromatic compound catabolic processes (p = 3.9 3 105),
owing to the presence of the three paraoxonase genes Pon1,
Pon2, and Pon3, in one of the SS PASS regions on Chr 4. Para-
oxonase genes protect against oxidative stress and have been
implicated in atherosclerosis and diabetes mellitus in humans
(Pre´court et al., 2011) and blood pressure regulation in mice
(Gamliel-Lazarovich et al., 2012). Oxidative stress is associated
with endothelial dysfunction and hypertension in humans and
in a wide range of experimental models, including the Dahl
SS rat (Kushiro et al., 2005; Swei et al., 1997; Vaziri and
Rodrı´guez-Iturbe, 2006). Because the paraoxonase genes over-
lap with SS QTLs for hypertension (Table S7), the paraoxonase
genes are compelling candidates as contributors to the hyper-
tension phenotype in the SS strain.
DISCUSSION
Laboratory rat strains have been studied extensively for cardio-
vascular and metabolic phenotypes for several decades, but the
vast majority of the genes and mutations underlying these
phenotypes remain to be identified. This is at least in part
because of the absence of the genome sequences and the
lack of comprehensive catalogs of genomic variants for these
strains. Previous catalogs of variants in the rat were restricted
to 20,238 SNVs in 167 inbred rat strains, which have been
used mostly as markers for QTL mapping (Saar et al., 2008).
More recently, the report of 3.6 million SNVs and 0.3 million
indels in the SHR strain has facilitated research aimed at under-
standing the mechanisms underlying complex traits in this strain
(Atanur et al., 2010; Heinig et al., 2010; McDermott-Roe et al.,
2011; Simonis et al., 2012). Another constraint has been that
existing data sets of rat variants are biased toward single-nucle-
otide changes, and apart from SHR, other types of variants such
as indels were partially or completely missing. This study reports
an extensive catalog of 9.6 million SNVs, 3.5 million short indels,
and 719,929 structural variants across 27 laboratory rat strains
that are among themost widely used animal models of hyperten-
sion and diabetes.
We used 2 Mb of high-quality BAC sequence from the non-
reference strain LE/Stm to estimate the false-positive and false-
negative rates of variant calling. Estimates of false positive and
false negatives reported in other model organisms have been
based on only the accessible part of the genome (Keane
et al., 2011), which may underestimate the false-negative rate
at the level of the whole genome. Although we estimate rela-
tively high false-negative rates (8.1% and 10.98% for SNVs
and indels, respectively), these false-negative rates are lower
than those reported for mouse genome sequences (Keane
et al., 2011) and represent upper estimates for missing variants
as measured against the entire reference genome, rather than
just the accessible genome. The false-positive rates were also
lower in our sequences than those reported by Keane et al. for
the mouse. The reasons for the lower false-positive and -nega-
tive rates may relate to the longer sequence reads and improved
algorithms for mapping and variant calling used in the present
studies.
We used the new sequence data from the 27 rat strains for two
main purposes: to provide a firm foundation for understanding
the phylogenetic history of the laboratory rat and to give new in-
sights into the genetic and pathophysiological basis of the dis-
ease phenotypes for which the various rat strains were selected.
Our phylogenetic analysis indicates that differences in laboratory
rat strains are primarily due to genetic differences in the founder
colonies fromwhich the rat strains were derived, reflecting differ-
ences that were most likely present in the original outbred
founder populations (Figure 1).
We used two approaches to give new insights into the ge-
netic and pathophysiological basis of disease phenotypes in
rat strains. First, we used the phylogenetic history of the strains
to identify clusters of genes with correlated evolutionary rates.Such methods have been widely used to identify coevolving
and functionally related proteins and small RNA pathways (de
Juan et al., 2013; Pagliarini et al., 2008; Pazos and Valencia,
2001; Tabach et al., 2013). We defined coevolutionary clusters
that were unique to each disease strain and among these
clusters of genes identified two genes, Add1 and Gimap5, pre-
viously shown by positional cloning to underlie susceptibility
to hypertension in MHS and lymphopenia and diabetes in
BBDP, respectively (Bianchi et al., 2005; Ferrandi et al., 2010;
Hornum et al., 2002; MacMurray et al., 2002). Given the small
number of genes shown to underlie rat disease phenotypes
(Aitman et al., 2008), the finding of Add1 in MHS and Gimap5
in BBDP in coevolutionary clusters for these strains provides
proof of concept of the efficacy of this approach in these rat
strains. We also found among the coevolutionary clusters for
MHS three further ion transport genes (Slc4a2, Slc12a8,
Atp13a4), of which one, Slc4a2, shows a predicted nonconser-
vative Gly/Asp amino acid substitution. The longstanding rela-
tionship between dysregulated ion transport and hypertension
in MHS rats and in humans (Bianchi et al., 1990; Lifton et al.,
2001) suggests these ion transporters as compelling candidates
as hypertension susceptibility genes. Given that the human
orthologs of rat genes within coevolutionary clusters showed
significant enrichment for GWAS hits for hypertension and
metabolism-related phenotypes, further study of these genes
may shed light on the pathogenetic mechanisms for these phe-
notypes in both species.
Our second approach to gaining new insights into disease
phenotypes was to identify putative selective sweeps, which
we term PASS regions, that were unique to individual strains
and may have been retained during the derivation of these dis-
ease models. Precedents for this type of analysis exist in the
study of domestication of other species, including maize, silk-
worm, chicken, and dog (Axelsson et al., 2013; Rubin et al.,
2010; Wright et al., 2005; Xia et al., 2009), but the approach
has not been applied previously to the study of disease pheno-
types. Our analyses took account of the known demographic
history of the rat strains and used several methods to distinguish
genomic segments that arose due to selection from those that
may have arisen from population structure.
First, the PASS regions that we identified as unique to individ-
ual rat strains ranged in length from 30 kb to 1.57 Mb, whereas a
null model obtained by coalescent simulation that took into
account demographic history identified no regions with length
> 30 kb. Second, we showed that LD was markedly increased
across PASS regions compared to the rest of the genome.
Third, we showed highly negative Tajima’s D values within
PASS regions, strongly supporting the presence of true selec-
tive sweeps among the identified PASS regions. Finally, we
found that the ratio of nonsynonymous-to-synonymous coding
variants in PASS regions was more than double that across
the rest of the genome (1.65 and 0.76, respectively). These
various approaches, used as indicators of evolutionary selection
in a variety of scenarios (Axelsson et al., 2013; Rubin et al., 2010;
Wright et al., 2005; Xia et al., 2009), strongly support the view
that the identified PASS regions are significantly enriched for
genomic segments retained by phenotype selection during deri-
vation of these strains.Cell 154, 691–703, August 1, 2013 ª2013 The Authors 699
The PASS regions that we identified were significantly en-
riched for cardiovascular or metabolic QTLs previously mapped
in these strains. In addition, where there was overlap between
QTLs and PASS regions, the majority of PASS regions were
localized at or close to the peak of the QTL linkage, in most
cases suggesting candidates for these QTLs and in some
cases single genes. These genes may now be tested in targeted
gene knockin or knockout experiments that may now be easily
performed in the rat on any genetic background (Jacob et al.,
2010).
To identify specific pathways that may have contributed to
phenotype-driven selection during derivation of disease strains,
we carried out GO analyses of genes within PASS regions
and identified enrichment for specific biological processes in
two strains, FHH and SS. PASS regions in FHH showed
enrichment for genes in the RAS and for proteolytic enzymes.
The finding of enrichment for genes in the RAS is not unex-
pected, given the central role of this system in blood pressure
regulation. However, canonical RAS genes that are either
hypertension susceptibility genes or drug targets are related
to ACE, whereas two of the genes in the FHH PASS regions
mediate non-ACE dependent conversion of angiotensin I to
angiotensin II. These genes, Cma1 and Ctsg, are therefore
compelling hypertension candidate genes, particularly as the
histidine at codon 94 in Cma1 that is uniquely variant in
FHH among all rat strains is conserved in all mammals. The
finding in FHH PASS regions of enrichment for mast cell pro-
teins, some of which show NSC variants at highly conserved
amino acids, suggests a previously unidentified pathway for
hypertension-induced nephropathy that is consistent with pre-
vious observations in human and rat hypertension, the mecha-
nism for which is at present unknown. Similar considerations
apply to the enrichment of genes associated with protection
against oxidative stress, found to be enriched in PASS regions
in SS.
We note that our analysis of PASS regions and coevolved
clusters across disease models did not identify shared
clusters of genes that were common to all strains that carry
the same disease phenotype, suggesting differing genetic
etiologies for complex traits across these disease models, as
previously suggested (Stoll et al., 2000). This may reflect the
differing pathophysiology of traits such as hypertension across
these strains (Jong, 1984) but is also likely due, in part, to the
different genetic backgrounds on which these models were
developed.
The data from these studies, including the genome se-
quences, catalogs of sequence variants, sets of coevolved
gene clusters, and PASS regions across 27 rat strains, repre-
sent a step change in the genome resources available for
study of complex phenotypes in the rat model. Identification
of genes underlying complex phenotypes in this model has
until now rested on laborious and lengthy gene-mapping
studies that have mostly localized disease genes to the
genome at a resolution of tens of mega base pairs. By
taking advantage of whole-genome sequences and population
structure in 27 strains, these studies identify coevolved seg-
ments and haplotype blocks that are unique to individual
disease strains. These genes and pathways, including those700 Cell 154, 691–703, August 1, 2013 ª2013 The Authorspreviously identified as QTL genes and unidentified genes
such as non-ACE-dependent angiotensin converting enzymes,
mast cell proteases, and proteins that protect against oxidative
stress, were most likely highlighted in these studies because
they were selected in the original phenotype-driven derivation
of these strains. We believe this to be the first evolutionary
analysis of artificial selection for disease phenotypes and sug-
gest that further analysis of these genes will confirm many of
them as new genes for these phenotypes that will shed
new light on the pathogenesis of these conditions in rats and
humans.EXPERIMENTAL PROCEDURES
Also see Extended Experimental Procedures.
Rat Strains and Genome Sequencing
We sequenced the genomes of 25 rat strains on the Illumina sequencing plat-
form (Table 1) and analyzed these together with two rat genomes that we
sequenced previously.
Mapping to the Reference Genome
Quality filtered Illumina paired-end and/or mate pair reads were mapped to
the BN reference genome RGSC-3.4 (Gibbs et al., 2004) using BWA-0.5.8c
(Li and Durbin, 2009). The genome (BN.Lx) sequenced previously on the
SOLiD sequencing platform was mapped using BFAST-0.6.4e (Homer et al.,
2009).
Single-Nucleotide Variants and Short Indel Detection
Genomic variants (single-nucleotide variants and short indels [1–15 bp])
were detected using the Genome Analysis Toolkit (GATK version 1.0.6001)
(DePristo et al., 2011; McKenna et al., 2010).
Structural Variant Prediction
To identify structural variants, we used two independent methods. Structural
variants including insertions, deletions, inversions, and translocations were
predicted using the software tool BreakDancer1.2 (Chen et al., 2009). In addi-
tion, large deletions were predicted using a custom Perl script as described
previously (Atanur et al., 2010), using mapping flags provided by BWA for
paired-end reads (Li and Durbin, 2009).
Functional Consequence Analysis of Predicted Variants
Functional consequences of predicted variants (SNVs and short indels) were
estimated using ‘‘variant effect predictor (VEP)-v2.4’’ (McLaren et al., 2010)
on the ENSEMBL 66 gene set.
Validation of Genomic Variants
To estimate sensitivity and specificity of variant calls, the sequence of 13 bac-
terial artificial chromosome (BAC) clones from various chromosomes (2 Mb
in length) of LE/Stm rat were downloaded from the EMBL web site (accession
numbers FO117624- FO117632 and FO181540- FO181543).
Reconstruction of the Phylogenetic Tree
Adistancematrix, derived fromSNVs between all possible pairs of strains, was
used to construct the phylogenetic tree using the Fitch-Margoliash method
with contemporary tips, version 3.69 from package Phylip (Felsenstein,
1989), with 1,000 bootstraps.
Identification of Coevolutionary Gene Clusters
Coevolutionary gene clusters were identified using a mirror tree approach. We
used two independent methods to correct for population structure: (1) prin-
cipal component analysis and (2) a linear mixture model.
Identification of Selective Sweeps between Different Rat Strains
To identify genomic regions shared between different rat strains, relative SNV
density (RSD) in nonoverlapping 10 kb windows was calculated in all 26 rat
strains (excluding BN.Lx) using the following formula:
RSDi =
Number of SNVs in strain i
Total number of SNVs
x 100
Chi-square statistics were used to determine the goodness of fit to a model
of equal distribution of SNVs within each 10 kb window between ‘‘n’’ strains.
Chi-square statistics were calculated for all possible combinations of strains
according to:
SC=min
 
n
k = 1.n
Xk
i = 1
ðOi  EiÞ2
Ei
!
Adjacent 10 kb windows were merged if they were shared between the
same strain combinations.
Calculation of Linkage Distribution
Linkage distribution between the SNVswithin the coevolutionary gene clusters
and SNVs within PASS regions was calculated using Haploview 4 (Barrett
et al., 2005).
Coalescent Simulations
Coalescent simulations were performed using the program msms (Ewing and
Hermisson, 2010).
Calculation of Population Genetics Statistics Tajima’s D
Tajima’s Dwas calculated in nonoverlapping 10 kbwindows using customPerl
script as described in (Tajima, 1989). FDR was calculated using the null distri-
bution of Tajima’s D from simulated data.ACCESSION NUMBERS
All sequence reads from this study are deposited in the EBI Sequence Read
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